<DOC>
	<DOCNO>NCT00610337</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled , Phase IIb study conduct North America Europe include male female subject acute cervical SCI , 18 62 year age , receive clinical trial material ( CTM ) within 72 hour injury . This study undertaken evaluate confirm safety efficacy CETHRIN® . This adaptive study design efficiently identify safe effective dose Phase IIb evaluate future Phase III study . Given current lack effective treatment SCI , improvement motor ability activity daily live subject would great advancement treatment SCI .</brief_summary>
	<brief_title>Safety Efficacy Cethrin® Adult Subjects With Acute Cervical Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>1 . Ability understand requirement study , provide informed consent , agree study restriction , agree return require assessment 2 . Males female , 18 62 year age , inclusive 3 . AIS Grade A , complete injury ability obtain accurate baseline assessment 4 . Motor neurological level C5 , C6 , C7 5 . Subjects acute cervical SCI schedule receive decompression/stabilization surgery 6 . Must willing able participate study procedures assessment 7 . Must medically stable 8 . If childbearing potential , woman must agree either follow duration 12month trial : ( ) abstinence , ( b ) sexually active , use one follow method birth control : barrier spermicide , intrauterine device , birth control hormone , surgical sterilization 9 . Must provide witness verbal authorization use disclosure protect health information ( PHI ) 1 . Subjects participate clinical trial involve investigational medication , device procedure within 30 day administration CTM 2 . Subjects require use mechanical ventilation 3 . Females positive serum pregnancy test 4 . Females breastfeed 5 . Preexisting SCI 6 . Subjects unable receive study medication within 72 hour injury 7 . Subjects peripheral nerve injury , brachial plexus injury , multifocal SCI 8 . Subjects injuries prevent comprehensive ASIA assessment 9 . Complete spinal cord transection 10 . Acute SCI gun shot knife wind 11 . Subjects mentally medically unstable , otherwise unlikely complete trial judgment investigator 12 . Subjects present history symptomatic cervical spondylotic myelopathy 13 . Subjects moderate severe traumatic brain injury Glasgow Coma Scale score less 14 14 . History multiple sclerosis neuromuscular disorder 15 . History adverse reaction fibrin sealant human bovine component 16 . Clinically significant neurological , cardiac , respiratory , hepatic , renal disease 17 . History cancer ( except basal cell carcinoma ) 18 . Hemophilia bleed abnormality 19 . Ankylosing spondylitis 20 . Use insulin therapy control diabetes mellitus within 6 month SCI 21 . Known immunodeficiency , include human immunodeficiency virus use immunosuppressive cancer chemotherapeutic drug 22 . Body mass index ( BMI ) ≥40 kg/m2 screening ( Appendix B include table height weight calculate BMI )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>